Thomas Landrain is co-founder and president of La Paillasse ['The Bench' in french, and to be pronounced 'Lah Payass'], the first french and one of the world largest community labs that fosters open science and technology. He claims that there is no monopole for great ideas and has been working on rebooting Science for the upcoming era of collective intelligence, fast prototyping and big data. He first did a career in academia after graduating in Genetics from Ecole Normale Superieure in Paris and co-founded the first french synthetic biology lab at Genopole where he did his PhD. He is also co-founder and CEO of PILI, a synthetic biology startup that uses fermentation to produce natural dyes for the textile, ink and cosmetic industry in place of petrochemistry and the agroindustry. Thomas is a strong advocate of open science and one of the most prominent spokesman for biohacking/DIYbio, regularly invited as an international speaker to share his visions and thoughts on the upcoming open biotech revolution. Today, La Paillasse has grown into an international network of laboratories with all necessary ressources to conduct prototyping and R&D projects, available to any person wishing to use it. It attracts a large number of explorers, entrepreneurs, scientists and creators. Finally, La Paillasse is experimenting on formats that could enable a more open, distributed and cooperative scientific research. Their first proof of concept is Epidemium, an open science program for the advance of Cancer Epidemiology that only uses and produces Open Data, launched in partnership with Roche Laboratories. For its first edition, Epidemium has mobilized more than 300 independent researchers in the region of Paris during 6 months, conducting to the creation of 15 different open research projects. La Paillasse is now working with academic and industrial partners on scaling this first promising experiment internationally and on more diverse research subjects.